In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs ...

Former Sen. Ben Sasse (R–Neb.), who previously served as president of the University of Florida, revealed in late December ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...

Learn why medical experts warn that "brushing off" common stomach issues could be a dangerous mistake and how your body ...